BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 14619251)

  • 1. Should commercial-in-confidence data be used by decision makers when making assessments of cost-effectiveness?
    Drummond M
    Appl Health Econ Health Policy; 2002; 1(2):53-4. PubMed ID: 14619251
    [No Abstract]   [Full Text] [Related]  

  • 2. Seeing the NICE side of cost-effectiveness analysis: a qualitative investigation of the use of CEA in NICE technology appraisals.
    Bryan S; Williams I; McIver S
    Health Econ; 2007 Feb; 16(2):179-93. PubMed ID: 16960851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of NICE technology appraisal in NHS rationing.
    Walker S; Palmer S; Sculpher M
    Br Med Bull; 2007; 81-82():51-64. PubMed ID: 17409119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prioritizing investments in health: can we assess potential value for money?
    Drummond M
    J Rheumatol Suppl; 2003 Dec; 68():19-20. PubMed ID: 14712616
    [No Abstract]   [Full Text] [Related]  

  • 5. Role of technology assessment in health benefits coverage for medical devices.
    Braslow NM; Shatin D; McCarthy DB; Newcomer LN
    Am J Manag Care; 1998 Sep; 4 Spec No():SP139-50. PubMed ID: 10185990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incorporation of genuine prior information in cost-effectiveness analysis of clinical trial data.
    Stevens JW; O'Hagan A
    Int J Technol Assess Health Care; 2002; 18(4):782-90. PubMed ID: 12602079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of the UK NHS purchaser-provider split on the 'rational' introduction of new medical technologies.
    Rosen R; Mays N
    Health Policy; 1998 Feb; 43(2):103-23. PubMed ID: 10177613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Down the road to product analysis, step by step. Medical Alley's Cost-Effectiveness Task Force.
    Mater Manag Health Care; 1995 Sep; 4(9):24. PubMed ID: 10151136
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparing estimates of cost effectiveness submitted to the National Institute for Clinical Excellence (NICE) by different organisations: retrospective study.
    Miners AH; Garau M; Fidan D; Fischer AJ
    BMJ; 2005 Jan; 330(7482):65. PubMed ID: 15601681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of cost-effectiveness analysis in health care decision-making.
    Magel JS
    Physician Exec; 1990; 16(3):31-2. PubMed ID: 10113233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The once and future application of cost-effectiveness analysis.
    Berger ML
    Jt Comm J Qual Improv; 1999 Sep; 25(9):455-61. PubMed ID: 10481814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How should cost-effectiveness analysis be used in health technology coverage decisions? Evidence from the National Institute for Health and Clinical Excellence approach.
    Williams I; Bryan S; McIver S
    J Health Serv Res Policy; 2007 Apr; 12(2):73-9. PubMed ID: 17407655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Making decisions on technology availability in the British National Health Service--why we need reliable models.
    Akehurst RL
    Value Health; 2003; 6(1):3-5. PubMed ID: 12535232
    [No Abstract]   [Full Text] [Related]  

  • 14. Expected value of information and decision making in HTA.
    Eckermann S; Willan AR
    Health Econ; 2007 Feb; 16(2):195-209. PubMed ID: 16981193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Globally optimal trial design for local decision making.
    Eckermann S; Willan AR
    Health Econ; 2009 Feb; 18(2):203-16. PubMed ID: 18435429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness analysis and innovation.
    Jena AB; Philipson TJ
    J Health Econ; 2008 Sep; 27(5):1224-36. PubMed ID: 18619695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health technology assessment in the United Kingdom.
    Akehurst R
    Value Health; 2010 Jun; 13 Suppl 1():S4-5. PubMed ID: 20618794
    [No Abstract]   [Full Text] [Related]  

  • 18. Analysis of uncertainty in health care cost-effectiveness studies: an introduction to statistical issues and methods.
    O'Brien BJ; Briggs AH
    Stat Methods Med Res; 2002 Dec; 11(6):455-68. PubMed ID: 12516984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. "We'll leave the light on.".
    Cannavo MJ
    Radiol Manage; 2002; 24(6):46-8. PubMed ID: 12546019
    [No Abstract]   [Full Text] [Related]  

  • 20. Expanding Health Technology Assessments to Include Effects on the Environment.
    Marsh K; Ganz ML; Hsu J; Strandberg-Larsen M; Gonzalez RP; Lund N
    Value Health; 2016; 19(2):249-54. PubMed ID: 27021760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.